These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12542402)

  • 1. Molecular targets in breast cancer: current status and future directions.
    Cristofanilli M; Hortobagyi GN
    Endocr Relat Cancer; 2002 Dec; 9(4):249-66. PubMed ID: 12542402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?
    Toss A; Venturelli M; Peterle C; Piacentini F; Cascinu S; Cortesi L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer--from clinic to laboratory.
    Gillett CE; Happerfield LC
    Br J Biomed Sci; 1997 Mar; 54(1):47-56. PubMed ID: 9167307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple-negative breast cancer: current state of the art.
    Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
    Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic Treatment of Early and Metastatic Breast Cancer].
    Fehm T; Müller V
    Dtsch Med Wochenschr; 2018 Dec; 143(24):1751-1754. PubMed ID: 30508853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary approach to breast cancer management.
    Levin M
    Drug News Perspect; 2004 Apr; 17(3):206-12. PubMed ID: 15179456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.
    Lang JE; Wecsler JS; Press MF; Tripathy D
    J Surg Oncol; 2015 Jan; 111(1):81-90. PubMed ID: 25091830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antiangiogenic drugs for the management of breast cancer: new approaches for an old issue?
    Bozza C; Fontanella C; Buoro V; Mansutti M; Aprile G
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):251-65. PubMed ID: 25597501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of pathologic complete response and the alteration of breast cancer immunohistochemical biomarkers after neoadjuvant chemotherapy.
    Shuai Y; Ma L
    Pathol Res Pract; 2019 Jan; 215(1):29-33. PubMed ID: 30501932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene targets of antisense therapies in breast cancer.
    Yang DC; Elliott RL; Head JF
    Expert Opin Ther Targets; 2002 Jun; 6(3):375-85. PubMed ID: 12223074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor markers of breast cancer].
    Sławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw (Online); 2004 Jul; 58():292-300. PubMed ID: 15280799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative angiogenesis in breast cancer.
    Fox SB
    Methods Mol Med; 2006; 120():161-87. PubMed ID: 16491601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for breast cancer.
    Beenken SW; Bland KI
    Minerva Chir; 2002 Aug; 57(4):437-48. PubMed ID: 12145573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis in breast cancer. Regulation, prognostic aspects, and implications for novel treatment strategies.
    Horak ER; Harris AL; Stuart N; Bicknell R
    Ann N Y Acad Sci; 1993 Nov; 698():71-84. PubMed ID: 7506508
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of proteomic technologies in breast cancer research.
    Mazur MG; Pyatchanina TV
    Exp Oncol; 2016 Sep; 38(3):146-57. PubMed ID: 27685521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shaping the future of biomarker research in breast cancer to ensure clinical relevance.
    Hinestrosa MC; Dickersin K; Klein P; Mayer M; Noss K; Slamon D; Sledge G; Visco FM
    Nat Rev Cancer; 2007 Apr; 7(4):309-15. PubMed ID: 17384585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast Cancer.
    Kim RN; Moon HG; Han W; Noh DY
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer.
    Carlson RW; Anderson BO; Burstein HJ; Cox CE; Edge SB; Farrar WB; Goldstein LJ; Gradishar WJ; Hayes DF; Hudis C; Jahanzeb M; Ljung BM; Marks LB; McCormick B; Nabell LM; Pierce LJ; Reed EC; Silver SM; Smith ML; Somlo G; Theriault RL; Ward JH; Winer EP; Wolff AC;
    J Natl Compr Canc Netw; 2005 May; 3(3):238-89. PubMed ID: 16002000
    [No Abstract]   [Full Text] [Related]  

  • 19. Neovascularization: an attractive but tricky target in thyroid cancer.
    Tasoulas J; Tsourouflis G; Theocharis S
    Expert Opin Ther Targets; 2018 Sep; 22(9):799-810. PubMed ID: 30124087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complex treatment of inflammatory breast cancer].
    Szántó J; Tóth J
    Magy Onkol; 2006; 50(4):303-7. PubMed ID: 17216003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.